Currently out of the existing stock ratings of Lu Li, 5 are a BUY (17.86%), 23 are a HOLD (82.14%).

Lu Li

Work Performance Price Targets & Ratings Chart

Analyst Lu Li, currently employed at UBS, has had 85.95% of price targets met with an average potential upside of 28.73%, reached in 72 days on average.

Lu Li has documented 56 price targets and ratings displayed on 5 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on QDEL, at 07-May-2026.

Wall Street Analyst Lu Li

Analyst best performing recommendations are on QDEL.
The best stock recommendation documented was for QDEL on 4/10/2026. The price target of $17 was fulfilled within 4 days with a profit of $3.15 (22.74%), with a performance score of 56.86.

Average potential price target upside

  • of $15.4 (4.47%) on WAT.
  • of $10.82 (30.86%) on VCYT.
  • of $7.46 (20.46%) on QDEL.
FLGT Fulgent Genetics MYGN QDEL VCYT WAT

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 13-Mar-2023

$25

$0.34 (1.38%)

$19

6 days ago
(10-Nov-2026)

Hold Since 05-Aug-2025

$30

1 years 3 months 11 days ago
(05-Aug-2025)

1/1 (100%)

$9.22 (44.37%)

108

Buy Since 18-Nov-2022

$25

$45

1 years 6 months 11 days ago
(05-May-2025)

1/2 (50%)

$5.44 (27.81%)

186

Hold Since 07-Dec-2023

$27

$25

2 years 3 months 11 days ago
(05-Aug-2024)

2/6 (33.33%)

$3.33 (14.07%)

309

Buy Since 20-Aug-2020

$125

$141

4 years 9 months 22 days ago
(25-Jan-2022)

4/8 (50%)

$61.5 (96.85%)

70

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Lu Li?

On 2024
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?